Постановление Правительства Пермского края от 24.12.2015 № 1139-п

¦      ¦                      ¦                  ¦суставных хрящей         ¦               ¦                              ¦           ¦

¦      ¦                      ¦                  ¦туловища и конечностей   ¦               ¦                              ¦           ¦

¦      ¦                      ¦                  ¦IIb-IVa,b стадии.        ¦               ¦                              ¦           ¦

¦      ¦                      ¦                  ¦Первичные                ¦               ¦                              ¦           ¦

¦      ¦                      ¦                  ¦злокачественные          ¦               ¦                              ¦           ¦

¦      ¦                      ¦                  ¦новообразования мягких   ¦               ¦                              ¦           ¦

¦      ¦                      ¦                  ¦тканей туловища и        ¦               ¦                              ¦           ¦

¦      ¦                      ¦                  ¦конечностей IIa-b, III,  ¦               ¦                              ¦           ¦

¦      ¦                      ¦                  ¦IV стадии                ¦               ¦                              ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               +------------------------------+           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦предоперационная или          ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦послеоперационная             ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦химиотерапия с проведением    ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦хирургического вмешательства  ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦в течение одной госпитализации¦           ¦

¦      +----------------------+------------------+-------------------------+---------------+------------------------------+-----------+

¦      ¦                      ¦        C48       ¦местнораспространенные и ¦комбинированное¦предоперационная или          ¦           ¦

¦      ¦                      ¦                  ¦метастатические формы    ¦лечение        ¦послеоперационная             ¦           ¦

¦      ¦                      ¦                  ¦первичных и рецидивных   ¦               ¦химиотерапия с проведением    ¦           ¦

¦      ¦                      ¦                  ¦неорганных опухолей      ¦               ¦хирургического вмешательства  ¦           ¦

¦      ¦                      ¦                  ¦забрюшинного пространства¦               ¦в течение одной госпитализации¦           ¦

¦      ¦                      ¦                  +-------------------------+---------------+------------------------------+           ¦

¦      ¦                      ¦                  ¦местнораспространенные   ¦комбинированное¦предоперационная или          ¦           ¦

¦      ¦                      ¦                  ¦формы опухолей брюшной   ¦лечение        ¦послеоперационная             ¦           ¦

¦      ¦                      ¦                  ¦стенки                   ¦               ¦химиотерапия с проведением    ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦хирургического вмешательства  ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦в течение одной госпитализации¦           ¦

¦      +----------------------+------------------+-------------------------+---------------+------------------------------+-----------+

¦      ¦                      ¦        C50       ¦первичный рак молочной   ¦комбинированное¦предоперационная или          ¦           ¦

¦      ¦                      ¦                  ¦железы T1-3N0-1M0        ¦лечение        ¦послеоперационная             ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦химиотерапия с проведением    ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦хирургического вмешательства  ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦в течение одной госпитализации¦           ¦

¦      ¦                      ¦                  +-------------------------+---------------+------------------------------+           ¦

¦      ¦                      ¦                  ¦первичный рак молочной   ¦комбинированное¦предоперационная              ¦           ¦

¦      ¦                      ¦                  ¦железы T1N2-3M0;         ¦лечение        ¦химиотерапия, в том числе в   ¦           ¦

¦      ¦                      ¦                  ¦T2-3N1-3M0               ¦               ¦сочетании с таргетными        ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦лекарственными препаратами, с ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦проведением хирургического    ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦вмешательства в течение одной ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦госпитализации                ¦           ¦

¦      ¦                      ¦                  +-------------------------+---------------+------------------------------+           ¦

¦      ¦                      ¦                  ¦метастатический и        ¦комбинированное¦предоперационная или          ¦           ¦

¦      ¦                      ¦                  ¦рецидивный рак молочной  ¦лечение        ¦послеоперационная             ¦           ¦

¦      ¦                      ¦                  ¦железы, предполагающий   ¦               ¦химиотерапия с проведением    ¦           ¦

¦      ¦                      ¦                  ¦использование на одном   ¦               ¦хирургического вмешательства  ¦           ¦

¦      ¦                      ¦                  ¦из этапов лечения        ¦               ¦в течение одной госпитализации¦           ¦

¦      ¦                      ¦                  ¦хирургического метода    ¦               ¦                              ¦           ¦

¦      +----------------------+------------------+-------------------------+---------------+------------------------------+-----------+

¦      ¦                      ¦        C53       ¦местнораспространенные   ¦комбинированное¦предоперационная или          ¦           ¦

¦      ¦                      ¦                  ¦формы рака шейки матки   ¦лечение        ¦послеоперационная             ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦химиотерапия с проведением    ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦хирургического вмешательства  ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦в течение одной госпитализации¦           ¦

¦      +----------------------+------------------+-------------------------+---------------+------------------------------+-----------+

¦      ¦                      ¦        C54       ¦злокачественные          ¦комбинированное¦послеоперационная             ¦           ¦

¦      ¦                      ¦                  ¦новообразования          ¦лечение        ¦химиотерапия с проведением    ¦           ¦

¦      ¦                      ¦                  ¦эндометрия II-III стадии ¦               ¦хирургического вмешательства  ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦в течение одной госпитализации¦           ¦

¦      +----------------------+------------------+-------------------------+---------------+------------------------------+-----------+

¦      ¦                      ¦        C56       ¦злокачественные          ¦комбинированное¦предоперационная или          ¦           ¦

¦      ¦                      ¦                  ¦новообразования яичников ¦лечение        ¦послеоперационная             ¦           ¦

¦      ¦                      ¦                  ¦I-IV стадии              ¦               ¦химиотерапия с проведением    ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦хирургического вмешательства  ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦в течение одной госпитализации¦           ¦

¦      ¦                      ¦                  +-------------------------+---------------+------------------------------+           ¦

¦      ¦                      ¦                  ¦рецидивы рака яичников   ¦комбинированное¦предоперационная или          ¦           ¦

¦      ¦                      ¦                  ¦                         ¦лечение        ¦послеоперационная             ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦химиотерапия с проведением    ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦хирургического вмешательства  ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦в течение одной госпитализации¦           ¦

¦      +----------------------+------------------+-------------------------+---------------+------------------------------+-----------+

¦      ¦                      ¦        C62       ¦местнораспространенный,  ¦комбинированное¦предоперационная или          ¦           ¦

¦      ¦                      ¦                  ¦метастатический и        ¦лечение        ¦послеоперационная             ¦           ¦

¦      ¦                      ¦                  ¦рецидивный рак яичка     ¦               ¦химиотерапия с проведением    ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦хирургического вмешательства  ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦в течение одной госпитализации¦           ¦

¦      ¦                      ¦                  +-------------------------+---------------+------------------------------+           ¦

¦      ¦                      ¦                  ¦рак яичка I-III стадии,  ¦комбинированное¦предоперационная или          ¦           ¦

¦      ¦                      ¦                  ¦T1-4N1-3M0-1             ¦лечение        ¦послеоперационная             ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦химиотерапия с проведением    ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦хирургического вмешательства  ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦в течение одной госпитализации¦           ¦

¦      +----------------------+------------------+-------------------------+---------------+------------------------------+-----------+

¦      ¦                      ¦        C64       ¦рак почки IV стадии,     ¦комбинированное¦послеоперационная             ¦           ¦

¦      ¦                      ¦                  ¦T3b-3c4,N0-1M1           ¦лечение        ¦лекарственная терапия с       ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦проведением хирургического    ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦вмешательства в течение одной ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦госпитализации                ¦           ¦

¦      +----------------------+------------------+-------------------------+---------------+------------------------------+-----------+

¦      ¦                      ¦   C65, C66, C67  ¦местнораспространенный   ¦комбинированное¦предоперационная или          ¦           ¦

¦      ¦                      ¦                  ¦уротелиальный рак        ¦лечение        ¦послеоперационная             ¦           ¦

¦      ¦                      ¦                  ¦T3-4N0M0 при             ¦               ¦химиотерапия с проведением    ¦           ¦

¦      ¦                      ¦                  ¦планировании             ¦               ¦хирургического вмешательства  ¦           ¦

¦      ¦                      ¦                  ¦органосохраняющей        ¦               ¦в течение одной госпитализации¦           ¦

¦      ¦                      ¦                  ¦операции                 ¦               ¦                              ¦           ¦

¦      ¦                      ¦                  +-------------------------+---------------+------------------------------+           ¦

¦      ¦                      ¦                  ¦местнораспространенный   ¦комбинированное¦предоперационная или          ¦           ¦

¦      ¦                      ¦                  ¦уротелиальный рак        ¦лечение        ¦послеоперационная             ¦           ¦

¦      ¦                      ¦                  ¦T1-4N1-3M0               ¦               ¦химиотерапия с проведением    ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦хирургического вмешательства  ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦в течение одной госпитализации¦           ¦

¦      +----------------------+------------------+-------------------------+---------------+------------------------------+-----------+

¦      ¦                      ¦  C00, C01, C02,  ¦опухоли головы и шеи у   ¦комбинированное¦предоперационная или          ¦           ¦

¦      ¦                      ¦  C03, C04, C05,  ¦детей: остеосаркома,     ¦лечение        ¦послеоперационная             ¦           ¦

¦      ¦                      ¦  C09, C10, C11,  ¦опухоли семейства        ¦               ¦химиотерапия с проведением    ¦           ¦

¦      ¦                      ¦ C30, C31, C41.0, ¦саркомы Юинга, саркомы   ¦               ¦хирургического вмешательства  ¦           ¦

¦      ¦                      ¦   C41.1, C49.0,  ¦мягких тканей,           ¦               ¦в течение одной госпитализации¦           ¦

¦      ¦                      ¦   C69.2, C69.4,  ¦хондросаркома,           ¦               ¦                              ¦           ¦

¦      ¦                      ¦       C69.6      ¦злокачественная          ¦               ¦                              ¦           ¦

¦      ¦                      ¦                  ¦фиброзная гистиоцитома,  ¦               ¦                              ¦           ¦

¦      ¦                      ¦                  ¦ретинобластома           ¦               ¦                              ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               +------------------------------+           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦комплексное лечение с         ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦применением высокотоксичных   ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦противоопухолевых             ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦лекарственных препаратов,     ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦включая таргетные             ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦лекарственные препараты, при  ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               +------------------------------+           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦развитии выраженных           ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦токсических реакций с         ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦применением сопроводительной  ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦терапии, требующей            ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦постоянного мониторирования в ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦стационарных условиях         ¦           ¦

¦      +----------------------+------------------+-------------------------+---------------+------------------------------+-----------+

¦      ¦                      ¦        C71       ¦опухоли центральной      ¦комбинированное¦предоперационная или          ¦           ¦

¦      ¦                      ¦                  ¦нервной системы у детей  ¦лечение        ¦послеоперационная             ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦химиотерапия с проведением    ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦хирургического вмешательства  ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦в течение одной госпитализации¦           ¦

¦      ¦                      ¦                  ¦                         ¦               +------------------------------+           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦комплексное лечение с         ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦применением высокотоксичных   ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦противоопухолевых             ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦лекарственных препаратов,     ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦включая таргетные             ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦лекарственные препараты, при  ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦развитии выраженных           ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦токсических реакций с         ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦применением сопроводительной  ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦терапии, требующей            ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦постоянного мониторирования в ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦стационарных условиях         ¦           ¦

¦      +----------------------+------------------+-------------------------+---------------+------------------------------+-----------+

¦      ¦                      ¦  C22, C34, C38,  ¦злокачественные          ¦комбинированное¦предоперационная или          ¦           ¦

¦      ¦                      ¦    C48.0, C52,   ¦новообразования          ¦лечение        ¦послеоперационная             ¦           ¦

¦      ¦                      ¦ C53.9, C56, C61, ¦торако-абдоминальной     ¦               ¦химиотерапия с проведением    ¦           ¦

¦      ¦                      ¦ C62, C64, C67.8, ¦локализации у детей      ¦               ¦хирургического вмешательства  ¦           ¦

¦      ¦                      ¦        C74       ¦(опухоли средостения,    ¦               ¦в течение одной госпитализации¦           ¦

¦      ¦                      ¦                  ¦опухоли надпочечника,    ¦               ¦                              ¦           ¦

¦      ¦                      ¦                  ¦опухоли печени, яичка,   ¦               ¦                              ¦           ¦

¦      ¦                      ¦                  ¦яичников, неорганные     ¦               ¦                              ¦           ¦

¦      ¦                      ¦                  ¦забрюшинные опухоли,     ¦               ¦                              ¦           ¦

¦      ¦                      ¦                  ¦опухоли почки,           ¦               ¦                              ¦           ¦

¦      ¦                      ¦                  ¦мочевыводящей системы и  ¦               ¦                              ¦           ¦

¦      ¦                      ¦                  ¦другие). Программное     ¦               ¦                              ¦           ¦

¦      ¦                      ¦                  ¦лечение                  ¦               ¦                              ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               +------------------------------+           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦комплексное лечение с         ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦применением высокотоксичных   ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦противоопухолевых             ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦лекарственных препаратов,     ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦включая таргетные             ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦лекарственные препараты, при  ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦развитии выраженных           ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦токсических реакций с         ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦применением сопроводительной  ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦терапии, требующей            ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦постоянного мониторирования в ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦стационарных условиях         ¦           ¦

¦      +----------------------+------------------+-------------------------+---------------+------------------------------+-----------+

¦      ¦                      ¦   C40, C41, C49  ¦опухоли                  ¦комбинированное¦предоперационная или          ¦           ¦

¦      ¦                      ¦                  ¦опорно-двигательного     ¦лечение        ¦послеоперационная             ¦           ¦

¦      ¦                      ¦                  ¦аппарата у детей.        ¦               ¦химиотерапия с проведением    ¦           ¦

¦      ¦                      ¦                  ¦Остеосаркома, опухоли    ¦               ¦хирургического вмешательства  ¦           ¦

¦      ¦                      ¦                  ¦семейства саркомы Юинга, ¦               ¦в течение одной госпитализации¦           ¦

¦      ¦                      ¦                  ¦злокачественная          ¦               ¦                              ¦           ¦

¦      ¦                      ¦                  ¦фиброзная гистиоцитома,  ¦               ¦                              ¦           ¦

¦      ¦                      ¦                  ¦саркомы мягких тканей    ¦               ¦                              ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               +------------------------------+           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦комплексное лечение с         ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦применением высокотоксичных   ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦противоопухолевых препаратов, ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦включая таргетные             ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦лекарственные препараты, при  ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦развитии выраженных           ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦токсических реакций с         ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦применением сопроводительной  ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦терапии, требующей            ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦постоянного мониторирования в ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦стационарных условиях         ¦           ¦

+------+----------------------+------------------+-------------------------+---------------+------------------------------+-----------+

¦  20  ¦Комплексное лечение с ¦ C81 - C90, C91.1 ¦первичные хронические    ¦терапевтическое¦комплексная                   ¦           ¦

¦      ¦применением           ¦  - 91.9, C92.1,  ¦лейкозы и лимфомы (кроме ¦лечение        ¦иммунохимиотерапия с          ¦           ¦

¦      ¦стандартной химио-    ¦   C93.1, C94.1,  ¦высокозлокачественных    ¦               ¦поддержкой ростовыми          ¦           ¦

¦      ¦и(или) иммунотерапии  ¦       C95.1      ¦лимфом, хронического     ¦               ¦факторами и использованием    ¦           ¦

¦      ¦(включая таргетные    ¦                  ¦миелолейкоза в фазе      ¦               ¦антибактериальной,            ¦           ¦

¦      ¦лекарственные         ¦                  ¦бластного криза и фазе   ¦               ¦противогрибковой,             ¦           ¦

¦      ¦препараты), лучевой и ¦                  ¦акселерации)             ¦               ¦противовирусной терапии,      ¦           ¦

¦      ¦афферентной терапии   ¦                  ¦                         ¦               ¦методов афферентной терапии и ¦           ¦

¦      ¦при первичных острых  ¦                  ¦                         ¦               ¦лучевой терапии               ¦           ¦

¦      ¦и хронических         ¦                  ¦                         ¦               ¦                              ¦           ¦

¦      ¦лейкозах и лимфомах   ¦                  ¦                         ¦               ¦                              ¦           ¦

¦      ¦(за исключением       ¦                  ¦                         ¦               ¦                              ¦           ¦

¦      ¦высокозлокачественных ¦                  ¦                         ¦               ¦                              ¦           ¦

¦      ¦лимфом, хронического  ¦                  ¦                         ¦               ¦                              ¦           ¦

¦      ¦миелолейкоза в стадии ¦                  ¦                         ¦               ¦                              ¦           ¦

¦      ¦бластного криза и     ¦                  ¦                         ¦               ¦                              ¦           ¦

¦      ¦фазе акселерации),    ¦                  ¦                         ¦               ¦                              ¦           ¦

¦      ¦рецидивах и           ¦                  ¦                         ¦               ¦                              ¦           ¦

¦      ¦рефрактерных формах   ¦                  ¦                         ¦               ¦                              ¦           ¦

¦      ¦солидных опухолей     ¦                  ¦                         ¦               ¦                              ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               +------------------------------+           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦комплексное лечение с         ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦использованием таргетных      ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦лекарственных препаратов,     ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦факторов роста,               ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦биопрепаратов, поддержкой     ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦стволовыми клетками           ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               +------------------------------+           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦комплексная химиотерапия с    ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦поддержкой ростовыми          ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦факторами и использованием    ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦антибактериальных,            ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦противогрибковых,             ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦противовирусных лекарственных ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦препаратов, методов           ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦афферентной терапии и лучевой ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦терапии                       ¦           ¦

+------+----------------------+------------------+-------------------------+---------------+------------------------------+-----------+

¦  21  ¦Дистанционная,        ¦  C00 - C14, C30, ¦злокачественные          ¦терапевтическое¦интраоперационная лучевая     ¦           ¦

¦      ¦внутритканевая,       ¦  C31, C32, C77.0 ¦новообразования головы и ¦лечение        ¦терапия, конформная           ¦           ¦

¦      ¦внутриполостная,      ¦                  ¦шеи (T1-4Nлюбая M0),     ¦               ¦дистанционная лучевая         ¦           ¦

¦      ¦стереотаксическая,    ¦                  ¦локализованные и         ¦               ¦терапия, в том числе IMRT,    ¦           ¦

¦      ¦радионуклидная        ¦                  ¦местнораспространенные   ¦               ¦IGRT, ViMAT,                  ¦           ¦

¦      ¦лучевая терапия в     ¦                  ¦формы                    ¦               ¦стереотаксическая.            ¦           ¦

¦      ¦радиотерапевтических  ¦                  ¦                         ¦               ¦Радиомодификация.             ¦           ¦

¦      ¦отделениях 3-го       ¦                  ¦                         ¦               ¦Компьютерная томография       ¦           ¦

¦      ¦уровня оснащенности,  ¦                  ¦                         ¦               ¦и(или) магнитно-резонансная   ¦           ¦

¦      ¦высокоинтенсивная     ¦                  ¦                         ¦               ¦топометрия. 3D - 4D           ¦           ¦

¦      ¦фокусированная        ¦                  ¦                         ¦               ¦планирование. Фиксирующие     ¦           ¦

¦      ¦ультразвуковая        ¦                  ¦                         ¦               ¦устройства. Плоскостная       ¦           ¦

¦      ¦терапия при           ¦                  ¦                         ¦               ¦и(или) объемная визуализация  ¦           ¦

¦      ¦злокачественных       ¦                  ¦                         ¦               ¦мишени. Интраоперационная     ¦           ¦

¦      ¦новообразованиях      ¦                  ¦                         ¦               ¦лучевая терапия               ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               +------------------------------+           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦конформная дистанционная      ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦лучевая терапия, в том числе  ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦IMRT, IGRT, ViMAT,            ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦стереотаксическая.            ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦Радиомодификация.             ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦Компьютерная томография       ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦и(или) магнитно-резонансная   ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦топометрия. 3D - 4D           ¦           ¦

¦      +----------------------+------------------+-------------------------+---------------+------------------------------+-----------+

¦      ¦                      ¦                  ¦                         ¦               ¦планирование. Фиксирующие     ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦устройства. Плоскостная       ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦и(или) объемная визуализация  ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦мишени                        ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               +------------------------------+           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦внутритканевая,               ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦аппликационная лучевая        ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦терапия. 3D - 4D              ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦планирование. Внутриполостная ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦лучевая терапия.              ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦Рентгенологический контроль   ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦установки эндостата           ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               +------------------------------+           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦внутритканевая,               ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦аппликационная лучевая        ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦терапия. 3D - 4D              ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦планирование. Внутриполостная ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦лучевая терапия.              ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦Рентгенологический контроль   ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦установки эндостата           ¦           ¦

¦      +----------------------+------------------+-------------------------+---------------+------------------------------+-----------+

¦      ¦                      ¦        C15       ¦рак пищевода (T1-4N      ¦терапевтическое¦конформная дистанционная      ¦           ¦

¦      ¦                      ¦                  ¦любая M0),               ¦лечение        ¦лучевая терапия, в том числе  ¦           ¦

¦      ¦                      ¦                  ¦локализованные и         ¦               ¦IMRT, IGRT, ViMAT,            ¦           ¦

¦      ¦                      ¦                  ¦местнораспространенные   ¦               ¦стереотаксическая.            ¦           ¦

¦      ¦                      ¦                  ¦формы                    ¦               ¦Радиомодификация.             ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦Компьютерная томография       ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦и(или) магнитно-резонансная   ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦топометрия. 3D - 4D           ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦планирование. Фиксирующие     ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦устройства. Плоскостная       ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦и(или) объемная визуализация  ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦мишени, синхронизация         ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦дыхания. Интраоперационная    ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦лучевая терапия               ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               +------------------------------+-----------+

¦      ¦                      ¦                  ¦                         ¦               ¦конформная дистанционная      ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦лучевая терапия, в том числе  ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦IMRT, IGRT, ViMAT,            ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦стереотаксическая.            ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦Радиомодификация.             ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦Компьютерная томография       ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦и(или) магнитно-резонансная   ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦топометрия. 3D - 4D           ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               +------------------------------+           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦планирование. Фиксирующие     ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦устройства. Плоскостная       ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦и(или) объемная визуализация  ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦мишени, синхронизация дыхания ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               +------------------------------+           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦внутриполостная лучевая       ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦терапия. Рентгенологический   ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦контроль установки эндостата. ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦3D - 4D планирование          ¦           ¦

¦      +----------------------+------------------+-------------------------+---------------+------------------------------+-----------+

¦      ¦                      ¦        C16       ¦рак желудка              ¦терапевтическое¦конформная дистанционная      ¦           ¦

¦      ¦                      ¦                  ¦(T2b-4aN0-3M0),          ¦лечение        ¦лучевая терапия, в том числе  ¦           ¦

¦      ¦                      ¦                  ¦локализованные и         ¦               ¦IMRT, IGRT, ViMAT,            ¦           ¦

¦      ¦                      ¦                  ¦местнораспространенные   ¦               ¦стереотаксическая.            ¦           ¦

¦      ¦                      ¦                  ¦формы                    ¦               ¦Радиомодификация.             ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦Компьютерная томография       ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦и(или) магнитно-резонансная   ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦топометрия. 3D - 4D           ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦планирование. Фиксирующие     ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦устройства. Плоскостная       ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦и(или) объемная визуализация  ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦мишени, синхронизация         ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦дыхания. Интраоперационная    ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦лучевая терапия               ¦           ¦

¦      +----------------------+------------------+-------------------------+---------------+------------------------------+-----------+

¦      ¦                      ¦    C17, C77.2    ¦рак тонкого кишечника,   ¦терапевтическое¦конформная дистанционная      ¦           ¦

¦      ¦                      ¦                  ¦локализованные и         ¦лечение        ¦лучевая терапия, в том числе  ¦           ¦

¦      ¦                      ¦                  ¦местнораспространенные   ¦               ¦IMRT, IGRT, ViMAT,            ¦           ¦

¦      ¦                      ¦                  ¦формы с метастазами во   ¦               ¦стереотаксическая фиксация.   ¦           ¦

¦      ¦                      ¦                  ¦внутрибрюшные            ¦               ¦Компьютерная томография       ¦           ¦

¦      ¦                      ¦                  ¦лимфатические узлы       ¦               ¦и(или) магнитно-резонансная   ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦топометрия. 3D - 4D           ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦планирование. Фиксирующие     ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦устройства. Плоскостная       ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦и(или) объемная визуализация  ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦мишени, синхронизация         ¦           ¦

¦      ¦                      ¦                  ¦                         ¦               ¦дыхания. Интраоперационная    ¦           ¦